研究目的
To summarize preclinical and clinical data on the safety and effectiveness of the EVO Implantable Collamer Lens (ICL) with a central port for correcting refractive errors.
研究成果
The EVO ICL is safe and effective for correcting a broad range of refractive errors, with high postoperative visual acuity, predictability, and stability. It shows reduced rates of complications like anterior subcapsular cataract and pupillary block compared to earlier models, making it a favorable option. Future studies should focus on longer-term outcomes and broader patient populations.
研究不足
The review is based on existing literature, which may have variations in study design, sample sizes, and follow-up durations. It does not include original experimental data, and some long-term outcomes beyond 5 years are not fully covered. Potential biases in the included studies and the exclusion of non-English publications are limitations.
1：Experimental Design and Method Selection:
A literature review was conducted using PubMed.gov to identify relevant articles on the EVO ICL. Articles were screened for relevance, and references were checked for additional publications.
2：Sample Selection and Data Sources:
67 peer-reviewed papers were included, with data from preclinical studies and clinical reports involving human eyes.
3：List of Experimental Equipment and Materials:
Not specified in the paper as it is a review; relies on data from cited studies.
4：Experimental Procedures and Operational Workflow:
Involved analysis of existing studies on fluid dynamics, optical effects, clinical outcomes (e.g., visual acuity, refractive error correction), and safety metrics.
5：Data Analysis Methods:
Meta-analysis and weighted averages were used to summarize data from multiple studies, including statistical comparisons (e.g., t-tests) where applicable.
独家科研数据包，助您复现前沿成果，加速创新突破
获取完整内容
